Myriad Genetics
MYGN
$18.49
Share price
-0.05%
Change (1 day)
-15.45%
Change (1 year)
Number of shares outstanding for Myriad Genetics (MYGN)
Number of shares outstanding as of April 2024 : 81,900,000
According to Myriad Genetics's latest financial reports and stock price the company's current number of shares outstanding is 81,900,000. At the end of 2023 the company had 81,900,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Myriad Genetics from 2009 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 81.9 M | 0.49% |
| 2022 | 81.5 M | 2% |
| 2021 | 79.9 M | 6.11% |
| 2020 | 75.3 M | 1.21% |
| 2019 | 74.4 M | 0.27% |
| 2018 | 74.2 M | 7.07% |
| 2017 | 69.3 M | 1.61% |
| 2016 | 68.2 M | -3.26% |
| 2015 | 70.5 M | -2.71% |
| 2014 | 72.46 M | -3.47% |
| 2013 | 75.07 M | -8.11% |
| 2012 | 81.69 M | -3.32% |
| 2011 | 84.49 M | -7.68% |
| 2010 | 91.52 M | -4.93% |
| 2009 | 96.27 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 1,734,076,358 | 2,017.31% | 🇺🇸 USA |
 Exact Sciences EXAS | 180,649,000 | 120.57% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 188,219,000 | 129.82% | 🇺🇸 USA |
 Biocept
BIOC | 1,036,529 | -98.73% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 29,102,000 | -64.47% | 🇺🇸 USA |